A study to test how well different doses of BI 3810477 are tolerated by healthy men

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513419-28-00

Acronym

1530-0001

Enrollment

Registered

2024-10-14

Start date

2024-10-22

Completion date

2025-06-12

Last updated

2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026